
Talima Therapeutics, Inc.: A US-based medical company specializing in site-specific drug delivery systems.
Talima Therapeutics, Inc. is a US-based medical company founded with the core mission of revolutionizing drug delivery systems. The company's vision is to enhance patient outcomes through innovative site-specific drug delivery technologies. Talima specializes in developing and commercializing micro implants that deliver drugs directly to targeted areas affected by infections and diseases. Their primary market focus is the medical and pharmaceutical industries across the United States.
Notable affiliated individuals and investors include key figures from the medical and pharmaceutical sectors who have supported Talima's growth and innovation. The company has achieved significant milestones in the development of its proprietary drug delivery systems, earning recognition for its contributions to improving patient care. Talima Therapeutics' impact lies in its ability to provide more effective and localized treatment options, thereby advancing the field of targeted drug delivery.

Tal Medical

Trilogic Pharma
trilogicpharma.com

Stealth Therapeutics

Tulavi Therapeutics
tulavi.com

On Demand Therapeutics

Therapyx
therapyxinc.com

Credence MedSystems

Mechano-Therapeutics

Intact Therapeutics

Ezra Innovations
ezrapharma.com

Toralgen
toralgen.com

Tela Bio
telabio.com

Micron Biomedical

Theracos
theracos.com

InSitu Biologics
Companies similar to Talima Therapeutics include Tal Medical, Trilogic Pharma, Stealth Therapeutics and Tulavi Therapeutics.
Talima Therapeutics was founded in 2004.
Talima Therapeutics' headquarters is located in San Carlos, CA, US.
Talima Therapeutics' most recent funding round was for $19M (USD) in May 2007.
As of May 29, 2007, Talima Therapeutics has raised a total of $20.6M (USD).
Talima Therapeutics has 2 employees as of Feb 5, 2024.